Jerusalem, 8 July, 2025 (TPS-IL) — Israeli MedTech firm Restore Medical has raised $23 million in a Series B funding round to advance its novel transcatheter device for heart failure therapy. The investment, co-led by Pitango HealthTech and a global strategic partner, will fund clinical trials in Europe and the U.S., following the device’s FDA Breakthrough designation.

Additional support came from the European Innovation Council (EIC) Fund and Peregrine Ventures. The minimally invasive device aims to address a critical gap in care for heart failure patients with limited treatment options.

TPS

See Full Bio